Product Images Gabapentin

This is a mathematical formula used to calculate the creatinine clearance (CLCr) in patients, which is a measure of how well their kidneys are functioning. The formula takes into account the patient's age, weight, and serum creatinine level. The result is adjusted for female patients using a multiplier of 0.85.*

The Moan Pain Score is 10. There is a 4-week dose titration period followed by a fixed dose period of 40k. There is also a placebo and Gabapentin of 3600 mg/day. The duration of the study is measured in weeks.*

This appears to be a chart showing the results of a study on different doses of Gabapentin for pain management over a 4-week period. There are three groups being compared, one receiving a placebo and the others receiving 1800mg/day or 2400mg/day of Gabapentin. The chart shows the mean pain score at baseline and then at 7 different time points over the 4-week period.*

The text provides information about the proportion of responders with more than 50% reduction in pain score in controlled PHN studies. The figure shows two studies where patients taking the medication had a higher percentage of responders compared to placebo. The text also includes the cost of GBP 3600 for the medication, GBP 1800 for placebo and GBP 2400 for an unknown product. Therefore, the text might be describing a medication used to treat PHN (postherpetic neuralgia) that is effective in reducing pain and more expensive than placebo.*

This is a description of a drug package for Neurontin 600mg Tablet manufactured by Vivimed Life Sciences Pvt Ltd. It includes details such as the package being packaged by Bryant Ranck Prepack and the expiration date of the tablets, which is MM/YY. The package also contains the NDC number and the storage instructions for the medication. The text ends with a warning about keeping all drugs out of reach of children.*